Vialwirebiotech, curated
July 20, 2026, 11:09 PM
July 14, 2026
- 8:27 PM · TechCrunch
- 5:35 PM · Pharmaceutical Executive5:35 PM<![CDATA[Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform]]> — Pharmaceutical Executive
- 12:20 PM · BioPharma Dive12:20 PMJudge orders Apple Tree partner to forfeit oversight of venture fund — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMIsland Pharma targets Ebola species lacking approved treatments — BioWorld
- 12:00 PM · BioWorld12:00 PMTakeda's mezagitamab adds quality-of-life gains to ITP responses — BioWorld
- 12:00 PM · BioWorld12:00 PMDrug Farm bags $55M series D to advance AI-developed ALPK1 drug — BioWorld
- 12:00 PM · BioWorld12:00 PMMed-tech companies slapped with historic FTC penalty — BioWorld
- 12:00 PM · BioWorld12:00 PMHLB, Hengrui receive third US FDA rejection on liver cancer combo — BioWorld
- 12:00 PM · BioWorld12:00 PMAstrazeneca nabs PDE3/4 inhibitor for COPD in $2.1B Sino deal — BioWorld
- 12:00 PM · BioWorld12:00 PMTeva’s beef with Lilly over Forteo settlement lives again — BioWorld
- 12:00 PM · BioPharma Dive12:00 PMFresh off buyout, Akero execs reunite to advance long-acting psoriasis pill — BioPharma Dive
- 11:00 AM · BioWorld11:00 AMCelia trial: data strong, analysts skeptical — BioWorld
- 10:14 AM · Pharmaceutical Technology10:14 AMAstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug — Pharmaceutical Technology
- 9:59 AM · BioPharma Dive9:59 AMDraig bags another $65M to speed testing of brain drugs — BioPharma Dive
- 9:24 AM · Pharmaceutical Executive9:24 AM<![CDATA[FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease]]> — Pharmaceutical Executive
- 9:15 AM · STAT News
- 9:00 AM · BioWorld9:00 AMNiagen’s NB-4168 designated orphan drug in EU — BioWorld
- 9:00 AM · BioWorld9:00 AMPreclinical data support Evaxion’s platform behind CMV vaccine candidate — BioWorld
- 6:10 AM · Drug Discovery World6:10 AMInsilico Medicine and CMS announce CNS disease collaboration — Drug Discovery World
- 6:00 AM · Pharmaceutical Executive6:00 AM<![CDATA[The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan]]> — Pharmaceutical Executive
- 5:30 AM · Drug Discovery World5:30 AMSofinnova Partners expands expertise with new partner — Drug Discovery World
- 5:10 AM · Drug Discovery World5:10 AMStudy proves preclinical efficacy of gene therapy for metabolic disorder — Drug Discovery World
- 4:57 AM · Pharmaceutical Technology4:57 AMNovartis and Chai Discovery collaborate on antibody identification — Pharmaceutical Technology
- 4:00 AM · Labiotech (EU)4:00 AMEnd-to-end: Curia drives supply and scale for steroid and hormonal therapies — Labiotech (EU)
- 3:39 AM · Pharmaceutical Technology3:39 AMCellares and Sonoma partner to automate cell therapy manufacturing — Pharmaceutical Technology
July 13, 2026
- 9:30 PM · FT — Pharmaceuticals9:30 PMDr Reddy’s runs into trouble with its weight-loss drug — FT — Pharmaceuticals
- 8:00 PM · Nature Biotechnology8:00 PMSangamo exits stage — Nature Biotechnology
- 5:25 PM · SCMP — Tech5:25 PMUS National Science Foundation to ban projects with flagged Chinese institutions — SCMP — Tech
- 4:58 PM · STAT News
- 2:35 PM · BioPharma Dive2:35 PMFreenome colorectal cancer test data improve on earlier results — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMFDA advances streamlined Rx registration path — BioWorld
- 12:00 PM · BioWorld12:00 PMJAKs or better: Q32 ups ante in AA with IL-7 antibody phase II — BioWorld
- 12:00 PM · BioWorld12:00 PMFed Circuit once again instructs on enablement of Rx claims — BioWorld
- 10:28 AM · Pharmaceutical Executive10:28 AM<![CDATA[Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration]]> — Pharmaceutical Executive
- 9:32 AM · Drug Discovery World9:32 AMNovogene Europe launches untargeted metabolomics service — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMConnecta’s TrkB allosteric modulator shows promise in fragile X model — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMGHIT Fund buoys malaria, TB, neglected tropical disease research — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMSL Science seeks US orphan drug designation for γδ T-cell therapy — BioWorld
- 9:00 AM · BioWorld9:00 AMNovartis prepares new FAP-targeting radioconjugates — BioWorld
- 9:00 AM · BioWorld9:00 AMShenzhen Linggene Biotechnology discloses new OGT degradation inducers — BioWorld
- 9:00 AM · BioWorld9:00 AMJAK2 inhibitors reported in Prelude Therapeutics patent — BioWorld
- 8:00 AM · BioWorld8:00 AMNeurovalens granted FDA approval for PTSD therapy for US veterans — BioWorld
- 7:00 AM · SCMP — Tech
- 6:27 AM · Drug Discovery World6:27 AMCancer Research UK leads global trial of rare cancer therapy — Drug Discovery World
- 5:13 AM · Pharmaceutical Technology5:13 AMTakeda and Indonesia partner on plasma-derived therapies — Pharmaceutical Technology
- 4:31 AM · Pharmaceutical Technology4:31 AMFDA approves MSD’s Keytruda combinations for MIBC — Pharmaceutical Technology